Concepedia

Jennifer Volkman

JV

5

Publications

441

Citations

5

H-Index

2003

Active since

Affiliations

University of Wisconsin–Madison(Current)

Spanish Oncology Genitourinary Group

University of Wisconsin Carbone Cancer Center

GlaxoSmithKline (United States)

Jennifer Volkman is an author at University of Wisconsin–Madison specializing in medicine, pharmacology, and cancer research.

Top concepts

Publications per year

2003–2010

5

Publications

5

A Phase I Trial of Perifosine (NSC 639966) on a Loading Dose/Maintenance Dose Schedule in Patients with Advanced Cancer

Lynn Van Ummersen, Kim Binger, Jennifer Volkman et al. · Clinical Cancer Research · 2004 · 157 citations

Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion

Douglas G. McNeel, Jens C. Eickhoff, Fred T. Lee et al. · Clinical Cancer Research · 2005 · 157 citations

, , +15

A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose

Kyle D. Holen, Chandra P. Belani, George Wilding et al. · Cancer Chemotherapy and Pharmacology · 2010 · 71 citations · Full text

, , +5

Phase I trial of novel kinesin spindle protein (KSP) inhibitor SB-715992 IV Q 21 days

Q. Chu, Kyle D. Holen, Eric K. Rowinsky et al. · Journal of Clinical Oncology · 2004 · 30 citations

, , +15

Phase I trial of perillyl alcohol administered four times daily continuously

Sherry Morgan-Meadows, Sarita Dubey, Michael N. Gould et al. · Cancer Chemotherapy and Pharmacology · 2003 · 26 citations

, , +6

Rows per page

1–5 of 5